[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Download PDF
Figure. Cutaneous halo nevi development following plaque radiotherapy for uveal melanoma. A, Wide-angle fundus photograph of the left eye in a 28-year-old woman shows a ciliochoroidal melanoma. B-E, Four months after treatment with iodine 125 plaque radiotherapy, halo (arrows) around multiple cutaneous nevi involving the face, neck, upper chest, and back were documented, with almost complete depigmentation of 1 of the nevi (arrowhead) (B).

Figure. Cutaneous halo nevi development following plaque radiotherapy for uveal melanoma. A, Wide-angle fundus photograph of the left eye in a 28-year-old woman shows a ciliochoroidal melanoma. B-E, Four months after treatment with iodine 125 plaque radiotherapy, halo (arrows) around multiple cutaneous nevi involving the face, neck, upper chest, and back were documented, with almost complete depigmentation of 1 of the nevi (arrowhead) (B).

1.
Speeckaert R, van Geel N, Vermaelen KV,  et al.  Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.  Pigment Cell Melanoma Res. 2011;24(2):334-344PubMedArticle
2.
Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA. Halo nevus of the choroid in 150 patients: the 2010 Henry van Dyke Lecture.  Arch Ophthalmol. 2010;128(7):859-864PubMedArticle
3.
Rhodes A. Neoplasms: benign neoplasias, hyperplasias, and dysplasias of melanocytes. In: Fitzpatrick TB, Eisen A, Wolff K, Freedberg I, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1987:877-918
4.
Shields CL, Furuta M, Berman EL,  et al.  Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases.  Arch Ophthalmol. 2009;127(8):981-987PubMedArticle
5.
Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. Vitiligo in patients with metastatic melanoma: a good prognostic sign.  J Am Acad Dermatol. 1983;9(5):689-696PubMedArticle
6.
Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB. Vitiligo or halo nevi occurring in two patients with choroidal melanoma.  Arch Dermatol. 1982;118(1):34-36PubMedArticle
7.
Duh EJ, Schachat AP, Albert DM, Patel SM. Long-term survival in a patient with uveal melanoma and liver metastasis.  Arch Ophthalmol. 2004;122(2):285-287PubMedArticle
8.
Nirankari MS, Khanna KK, Mathur RP. Uveal malignant melanoma with leucoderma.  J All India Ophthalmol Soc. 1968;16(2):63-66PubMed
Research Letters
Nov 2011

Cutaneous Halo Nevi Following Plaque Radiotherapy for Uveal Melanoma

Author Affiliations

Author Affiliations: Department of Ocular Oncology, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania (Drs Sarici, Shah, C. L. Shields, and J. A. Shields); and Department of Ophthalmology, Walter Reed Army Medical Center, Washington, DC (Dr Birdsong).

Arch Ophthalmol. 2011;129(11):1499-1501. doi:10.1001/archophthalmol.2011.313

Halo nevi have been described in both dermatology and ophthalmology.1,2 Cutaneous halo nevi are found more often in children than adults and are believed to result from an immune response.3 Choroidal halo nevus represents 5% of all choroidal nevi and displays low risk for transformation to melanoma.4 The development of cutaneous halo nevi or vitiligo in adulthood can occur following treatment of cutaneous melanoma and correlates with decreased morbidity, presumably due to activation of a systemic immune response.5 There have been rare reports of vitiligo and/or cutaneous halo nevi development following enucleation for uveal melanoma.6,7 A comprehensive study on choroidal halo nevi found a statistical association with history of skin melanoma.2 Herein, we describe a young woman with uveal melanoma who developed a halo ring around numerous pigmented cutaneous nevi following plaque radiotherapy for uveal melanoma.

Report of a Case

A 28-year-old woman with photopsia in the left eye was diagnosed as having choroidal melanoma. There was no history of cutaneous melanoma. Visual acuity was 20/20 OD and 20/25 OS. The melanoma measured 14 mm in basal dimension and 7 mm in thickness (Figure, A).

Iodine 125 plaque radiotherapy was performed. Two months after therapy, the patient reported development of a noninflammatory, painless, circumscribed halo around numerous previously pigmented cutaneous nevi, and 1 nevus lost nearly all pigmentation (Figure, B-E). At 4 months, the uveal melanoma regressed to 3.7 mm in thickness. Metastatic evaluation findings were negative.

Comment

Cutaneous melanoma can stimulate vitiligo or halo nevi through immune mechanisms. The proposed pathophysiology involves cytotoxic T-cell–mediated immune reaction targeted against antigens shared between normal melanocytes and melanoma cells such as MART-1, tyrosinase, gp100, TYRP1, and TYRP2.1 Histopathologically, a lymphohistiocytic infiltrate predominated by CD4 and CD8 T cells has been observed at the margin of such depigmented lesions.1 Immunotherapeutic strategies for cutaneous melanoma have been attempted based on this observation.1

In 1968, Nirankari et al8 described a 57-year-old man who underwent evisceration for panophthalmitis from undetected uveal melanoma. He developed vitiligo at 9 years and orbital recurrence of uveal melanoma at 11 years, for which orbital exenteration was performed. In 1982, Albert et al6 described 2 patients with skin depigmentation following enucleation for melanoma. Case 1 was a 69-year-old man who developed vitiligo 5 years after enucleation, and case 2 was a 36-year-old man who developed cutaneous halo nevi 1 year after enucleation. Albert and colleagues speculated that this represented a heightened host response and more favorable prognosis. In 2004, Duh et al7 described a 74-year-old woman with a 12.8-mm-thick uveal melanoma who developed vitiligo 6 years after enucleation. These reports suggest a possible role of the immune system following therapy of uveal melanoma, similar to cutaneous melanoma. We are not aware of other cases of cutaneous halo nevi developing after plaque radiotherapy for uveal melanoma.

The association of cutaneous halo nevus or vitiligo with treated uveal melanoma could be more frequent because these dermal findings can be subtle, as in our case.

Back to top
Article Information

Correspondence: Dr C. L. Shields, Department of Ocular Oncology, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Ste 1440, Philadelphia, PA 19107 (carol.shields@shieldsoncology.com).

Financial Disclosure: None reported.

Funding/Support: This study was supported by the Eye Tumor Research Foundation, Philadelphia, Pennsylvania.

References
1.
Speeckaert R, van Geel N, Vermaelen KV,  et al.  Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.  Pigment Cell Melanoma Res. 2011;24(2):334-344PubMedArticle
2.
Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA. Halo nevus of the choroid in 150 patients: the 2010 Henry van Dyke Lecture.  Arch Ophthalmol. 2010;128(7):859-864PubMedArticle
3.
Rhodes A. Neoplasms: benign neoplasias, hyperplasias, and dysplasias of melanocytes. In: Fitzpatrick TB, Eisen A, Wolff K, Freedberg I, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1987:877-918
4.
Shields CL, Furuta M, Berman EL,  et al.  Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases.  Arch Ophthalmol. 2009;127(8):981-987PubMedArticle
5.
Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. Vitiligo in patients with metastatic melanoma: a good prognostic sign.  J Am Acad Dermatol. 1983;9(5):689-696PubMedArticle
6.
Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB. Vitiligo or halo nevi occurring in two patients with choroidal melanoma.  Arch Dermatol. 1982;118(1):34-36PubMedArticle
7.
Duh EJ, Schachat AP, Albert DM, Patel SM. Long-term survival in a patient with uveal melanoma and liver metastasis.  Arch Ophthalmol. 2004;122(2):285-287PubMedArticle
8.
Nirankari MS, Khanna KK, Mathur RP. Uveal malignant melanoma with leucoderma.  J All India Ophthalmol Soc. 1968;16(2):63-66PubMed
×